Bio Protocol (BIO) continues to trade around $0.03242, showing steady short-term strength after a sharp increase in activity across both price and volume.
Over the last 24 hours, the token has gained 5.8%, outperforming the broader crypto market, which recorded a 1.41% rise over the same period.
This divergence highlights a more aggressive flow of capital into BIO compared to the wider market environment.
Volume surge drives short-term momentum
One of the most notable developments in BIO’s recent trading activity is the extreme expansion in volume.
Market data shows a 24-hour trading volume increase of approximately 697%, reaching around $222.85 million, with other snapshots placing it near $193 million.
This surge stands out as significantly higher than typical baseline activity for the token.
Such a sharp rise in participation often signals concentrated market activity rather than gradual accumulation.
In this case, the combination of the rising price and the rapidly expanding volume indicates strong demand pressure within a short timeframe.
This type of market behaviour is commonly associated with repositioning phases where liquidity shifts quickly into a single asset.
The price increase of 5.8% in BIO compared to the broader market’s 1.41% gain further reinforces that the move is not purely driven by macro conditions.
Instead, it reflects token-specific flow strength, with BIO capturing a disproportionate share of trading activity relative to the wider sector.
Additional context from the broader market shows a modest improvement in altcoin sentiment, with the CoinMarketCap Altcoin Season Index rising to 40, marking an 8.11% increase.
While not indicating a full altcoin cycle, this shift provides a supportive environment for mid-cap tokens experiencing sudden volume inflows.
Bio Protocol price technical outlook
The current BIO price structure remains centred around a critical level at $0.03217, which now acts as the main short-term pivot, aligning with the 50% retracement level.
As long as the Bio Protocol price holds above this zone, the structure maintains a bullish bias, supported by the recent expansion in trading activity.
On the upside, the first resistance level is positioned at $0.0348, followed by $0.0372 and $0.0384; all aligning with recent intraday highs.
A sustained move beyond these zones opens a pathway toward $0.04059, which represents a psychological and technical threshold.
The next target is at $0.0418, which corresponds to a previous 90-day high level and serves as a key breakout point for medium-term trend continuation.
A clean break above this zone would place the market in a higher expansion phase, where liquidity-driven momentum could extend further, with the next logical target at the previous high of $0.04812.
But in case of a pullback, a break below $0.0320 shifts focus toward $0.0303, followed by $0.0276.
A deeper retracement could extend toward the $0.0250–$0.0270 region, which previously acted as a structural base during earlier accumulation phases.
The post Bio Protocol price outlook: $0.045 rebound possible amid extended consolidation appeared first on Invezz
